Yu, Zhang, and colleagues demonstrate here that locally delivering CpG-Stat3siRNA enhances the efficacies of systemic PD-1 and/or CTLA4 blockade in two mouse tumor models and a xenograft tumor model. Here, CTLA4 is linked to neoplasm.